4ign
From Proteopedia
Jump to navigationJump to search
2.32 Angstrom X-ray Crystal structure of R47A mutant of human ACMSD
| ||||||||||||
Structural highlights
FunctionACMSD_HUMAN Converts alpha-amino-beta-carboxymuconate-epsilon-semialdehyde (ACMS) to alpha-aminomuconate semialdehyde (AMS). ACMS can be converted non-enzymatically to quinolate (QA), a key precursor of NAD, and a potent endogenous excitotoxin of neuronal cells which is implicated in the pathogenesis of various neurodegenerative disorders. In the presence of ACMSD, ACMS is converted to AMS, a benign catabolite. ACMSD ultimately controls the metabolic fate of tryptophan catabolism along the kynurenine pathway.[1] [2] References
| ||||||||||||||||||||
This page was last modified 11:56, 1 March 2024.